MediBuddy records 83.7% surge in at-home lab testing in metros, 56% in non-metro cities

The company's campaign is in line with the dramatically increased lab testing done by its users through the digital healthcare platform

New Delhi: MediBuddy, one of India’s leading digital healthcare platform has witnessed dramatic increase in lab testing done by its users.
Among the lab testing users, 82% did RTPCR tests, around 69% booked regular diabetes tests, followed by thyroid tests done by 67% and a full-body health check-up was taken by 84%.
The maximum lab tests were recorded on the platform from the top five metros, Delhi (NCR), Mumbai, Pune, Bengaluru, and Hyderabad. The metro cities experienced an increase of 83.7% in lab testing from home, while non-metro cities saw a spike of 56%.
The digital healthcare platform registered a growth rate of 3.67 % for those aged 12 to 18 years, 56.5 % for those aged 19 to 30, 27.3 % for those aged 31 to 40, followed by11.73 % for those aged 40 to 50, and 0.8 % for those aged 50 and up.
The company has launched its new campaign #LabsFromHome, urging people to prioritise their health and inculcate the habit of preventive health-checkup with super convenient at-home body test services.
Commenting on the same, Satish Kannan, Co-founder and CEO, MediBuddy, said, “The COVID-19 pandemic has urged individuals to take-charge of their health. With regular care, one can easily detect and diagnose diseases or health issues at an early stage with little risk of aggravating them. With our campaign #LabsFromHome using a conversational and light tone, we wanted to communicate the importance of testing, and, at the same time, we wanted to urge people to inculcate regular tests as part of their health regime. It’s been our constant endeavour to make high-quality healthcare accessible across the country.”